Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("RYU, M.-H")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 19 of 19

  • Page / 1
Export

Selection :

  • and

Analysis of serum protein biomarkers, circulating tumor DNA, and dovitinib activity in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumorsYOO, C; RYU, M.-H; NA, Y. S et al.Annals of oncology. 2014, Vol 25, Num 11, pp 2272-2277, issn 0923-7534, 6 p.Article

Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinumYOON, D. H; RYU, M.-H; PARK, Y. S et al.British journal of cancer. 2012, Vol 106, Num 6, pp 1039-1044, issn 0007-0920, 6 p.Article

Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)KANG, Y.-K; CHANG, H.-M; PARK, Y. S et al.British journal of cancer. 2013, Vol 108, Num 6, pp 1245-1251, issn 0007-0920, 7 p.Article

Effect of rebamipide on the glycosaminoglycan content of the ulcerated rat stomachSONG, D.-U; RYU, M.-H; CHAY, K.-O et al.Fundamental & clinical pharmacology. 1998, Vol 12, Num 5, pp 546-552, issn 0767-3981Article

Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinibKANG, Y.-K; YOO, C; RYU, M.-H et al.British journal of cancer. 2013, Vol 109, Num 9, pp 2309-2315, issn 0007-0920, 7 p.Article

Phase II and UGTIAI genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancerJO, J.-C; LEE, J.-L; RYU, M.-H et al.British journal of cancer. 2012, Vol 106, Num 10, pp 1591-1597, issn 0007-0920, 7 p.Article

Phase II study of S-I combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activityKIM, K-P; JANG, G; CHANG, H.-M et al.British journal of cancer. 2011, Vol 104, Num 4, pp 605-612, issn 0007-0920, 8 p.Article

A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancerKANG, H. J; CHANG, H. M; KIM, T. W et al.British journal of cancer. 2008, Vol 98, Num 2, pp 316-322, issn 0007-0920, 7 p.Article

A randomised multicentre phase II trial of capecitabine vs S-I as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancerLEE, J.-L; KANG, Y.-K; RYU, M.-H et al.British journal of cancer. 2008, Vol 99, Num 4, pp 584-590, issn 0007-0920, 7 p.Article

Wireless parallel operation of high voltage DC power supply using steady-state estimationBAEK, J. W; RYU, M. H; YOO, D. W et al.IEEE Industial Electronics Society. Annual conference. 2004, isbn 0-7803-8730-9, 3Vol, Vol2, 1856-1860Conference Paper

Semiconductor switches based pulse power generator for plasma source ion implantationKIM, J. H; RYU, M. H; SHENDEREY, S et al.IEEE international power modulator conference. 2004, pp 378-382, isbn 0-7803-8586-1, 1Vol, 5 p.Conference Paper

Pulse power supply using an IGBT switch stack for plasma source ion implantationKIM, J. H; RYU, M. H; SHENDEREY, S et al.Power electronics specialists conference. 2004, pp 806-809, isbn 0-7803-8399-0, 6Vol, 4 p.Conference Paper

Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysisKIM, H. S; KIM, H. J; KIM, S. Y et al.Annals of oncology. 2013, Vol 24, Num 11, pp 2850-2854, issn 0923-7534, 5 p.Article

Investigation of papulopustular eruptions caused by cetuximab treatment shows altered differentiation markers and increases in inflammatory cytokinesHAN, S. S; LEE, M; PARK, G. H et al.British journal of dermatology (1951). 2010, Vol 162, Num 2, pp 371-379, issn 0007-0963, 9 p.Article

Methylation of specific CpG sites in the promoter region could significantly down-regulate p16INK4a expression in gastric adenocarcinomaSONG, S. H; JONG, H.-S; CHOI, H. H et al.International journal of cancer. 2000, Vol 87, Num 2, pp 236-240, issn 0020-7136Article

Phase ii study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapyKANG, H. J; CHANG, H. M; KIM, T. W et al.British journal of cancer. 2005, Vol 92, Num 2, pp 246-251, issn 0007-0920, 6 p.Article

Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancerKIM, T. W; CHANG, H. M; KANG, H. J et al.Annals of oncology. 2003, Vol 14, Num 7, pp 1115-1120, issn 0923-7534, 6 p.Article

Cutaneous metastasis resembling acute dermatitis in patient with advanced gastric cancerKOO, D. H; CHANG, H. M; KANG, Y. K et al.Clinical and experimental dermatology (Print). 2007, Vol 32, Num 3, pp 284-286, issn 0307-6938, 3 p.Article

Prognostic significance of p53 gene mutations and protein overexpression in localized gastrointestinal stromal tumoursRYU, M. H; KANG, Y. K; LEE, J. L et al.Histopathology. 2007, Vol 51, Num 3, pp 379-389, issn 0309-0167, 11 p.Article

  • Page / 1